EliteImmune
Business Services · Maryland, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
704 Quince Orchard Rd Ste 215, Gaithersb...Phone Number
(240) 654-4956Website
www.eliteimmune.comRevenue
<$5 MillionIndustry
About EliteImmune
EliteImmune is dedicated to accelerating the discovery of potent and broad-spectrum antibody therapeutics, focusing on infectious diseases, oncology, and aging. The company utilizes advanced science-driven discovery and high-resolution technologies to identify superior therapeutic antibodies. With a robust pipeline and state-of-the-art research facilities, EliteImmune aims to serve as an external R&D engine for innovation in the biotherapeutics sector. Their services include funded discovery, Ig-seq analysis, and providing featured reagents to support collaborative drug discovery efforts.Explore more
EliteImmune Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to EliteImmune
Compare insights from companies similar to EliteImmune, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
EliteImmune Tech Stack
A closer look at the technologies used by EliteImmune
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding EliteImmune
Sign Up For FreeTo access detailed company insights
EliteImmune is dedicated to accelerating the discovery of potent and broad-spectrum antibody therapeutics, focusing on infectious diseases, oncology, and aging. The company utilizes advanced science-driven discovery and high-resolution technologies to identify superior therapeutic antibodies. With a robust pipeline and state-of-the-art research fac... Read More
